 News June 4 2021
Preclinapps is carrying out a research program to investigate 3D printing of drug deliv...
|
 |
PRICE QUOTE AND TECHNICAL INQUIRIES |

FOLLOW US
 |
|
|
MedRod速, a hormone implantRegistered trademark developed by Preclinapps
MedRod速 implant delivers active ingredient in efficient and reliable manner to support and improve the quality of preclinical studies. It is stable and cost-effective substitute to chronic injections. What is MedRod速
- Long-term drug release from a week to years
- Estrogens, androgens, progestins, glucocorticoids and other small molecules (such as 17beta estradiol, DHT, testosterone)
- Dose range from 10 ng/day up to 200 mcg/day
- Elastic and biocompatible soft matrix
- Very good performance in nude mice (athymic nude, NSG, NOD, Balb/c and NOG)
- Each batch and dosage validated unlike competing long-term drug delivery systems
|  | Do you know the release rate of your drug delivery system? Is it based on assumption or real measurements? When generating hormone dependent PDX, xenograft or syngeneic tumor studies it is vital to know exact release rate of hormones to avoid adverse effects and to promote optimal tumor growth.
|  |
Updated
4 June, 2021
|  | |
|